Digestive changes are also typical: digestion speeds up, hunger may become more frequent, and bowel patterns can shift
In particular, newer incretin-based therapies, including GLP-1 and dual-hormone agents, have changed the landscape of medical weight loss treatment by producing clinically meaningful and sustained weight loss for many patients
doi: 10.1002/edm2.70045 14 YamaneSHaradaNInagakiN
This article examines the biological mechanisms behind discontinuation effects, expected timelines, and evidence-based approaches to managing your weight after stopping treatment
Between 50% and 65% of patients quit within the first year, usually over cost, side effects or coverage barriers
What other questions need to be studied and assessed